Researcher
Ben Sprangers
- Keywords (Hasselt University):Biomedical sciences (incl. biochemistry)
- Disciplines (Hasselt University):Immunology not elsewhere classified, Kidney diseases
- Disciplines (KU Leuven):Immunology
- See also: Ben SPRANGERS (Hasselt University)
Affiliations
- Immunology & Infection (Department)
Member
From1 Jun 2022 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jun 2022 → Today - Biomedical Research Institute (Research institute)
Member
From1 Jun 2022 → 22 Jan 2024 - Immunology & Infection (Research group)
Member
From1 Jun 2022 → 22 Jan 2024 - Molecular Immunology (Rega Institute) (Lab)
Member
From1 Jan 2019 → Today - Tracheal Transplantation (Lab)
Member
From1 Feb 2010 → 31 Dec 2018 - Nephrology and Renal Transplantation Research Group (Division)
Member
From1 Oct 2003 → 31 Jul 2007
Projects
1 - 10 of 12
- Kidney stem/progenitor cells as a potent source for kidney-targeted cell therapyFrom2 Mar 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Kidney stem/progenitor cells as a potent source for kidney-targeted cell therapyFrom1 Oct 2021 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Developing approaches to allow the safe and effective use of checkpoint inhibitors in solid organ transplant patientsFrom1 Mar 2021 → 30 Jun 2022Funding: Foundations, funds and other with scientific goal
- Further confirmation of the therapeutic potential of Toll Like Receptor 9 (TLR9) antagonists on type 2 airway Inflammation: allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyps (CRSwNP)From1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Focal segmental glomerulosclerosis (FSGS) in the Flemish population: overview of epidemiological characteristics and pathophysiological analysis using single-cell and single-nucleus RNA-sequencing techniques.From1 Oct 2020 → TodayFunding: FWO fellowships
- Atomic Force Microscopy Enhanced Spectroscopy to Study Strains and Seeding of Amyloids In SituFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Redesigning allogeneic bone marrow transplantation as immunotherapyfor solid cancersFrom24 Oct 2018 → 30 Sep 2020Funding: BOF - Other initiatives
- Redesigning allogeneic bone marrow transplantation as immunotherapy for solid cancersFrom1 Oct 2018 → 30 Sep 2023Funding: FWO fellowships
- Mass cytometry by time-of-flight: next-generation flow cytometry for multiplexed single cell analysisFrom1 May 2018 → 30 Apr 2022Funding: FWO Medium Size Research Infrastructure
- Development of a technology platform for next-generation cytometryFrom1 Jul 2016 → 30 Jun 2020Funding: FWO Large scale research infrastructure
Publications
1 - 10 of 188
- Epidemiology and clinicopathological characteristics of native kidney disease in children in Flanders, Belgium(2023)
Authors: Dries Deleersnijder, Ben Sprangers
Pages: 1533 - 1545 - Predicting short- and long-term renal function following partial and radical nephrectomy(2023)
Authors: Annouschka Laenen, Ben Van Cleynenbreugel, Ben Sprangers, Benoit Beuselinck, Hendrik Van Poppel, Steven Joniau, Maarten Albersen
Pages: 1100 - 110000000 - Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders(2023)
Authors: Dries Deleersnijder, Evert Cleenders, Ben Sprangers
Pages: 125 - 137 - De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells(2022)
Authors: Sara Akalay, Kurt Vermeire, Ben Sprangers, Elena Levtchenko
Pages: 2791 - 2803 - Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation(2022)
Authors: Elisabet Van Loon, Maarten Coemans, Jasper Callemeyn, Dirk Kuypers, Ben Sprangers, Marie-Paule Emonds, Maarten Naesens
Pages: 718 - + - Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies(2022)
Authors: Thibaut Vaulet, Elisabet Van Loon, Jasper Callemeyn, Marie-Paule Emonds, Katrien De Vusser, Ben Sprangers, Dirk Kuypers, Maarten De Vos, Bart De Moor, Maarten Naesens
Pages: 2026 - 2039 - Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer(2022)
Authors: Ben Sprangers
Pages: 930 - 935 - Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury(2022)
Authors: Ben Sprangers
Pages: 794 - 805 - 'Prevention is better than cure': warning for comedications in patients receiving immune checkpoint inhibitors to avoid acute kidney injury(2022)
Authors: Ben Sprangers
Pages: 1803 - 1806 - Improving Cancer Care for Patients With CKD : The Need for Changes in Clinical Trials(2022)
Authors: Ben Sprangers
Pages: 1939 - 1950
Patents
1 - 3 of 3